Substrate and inhibitor specificities for human monoamine oxidase A and B are influenced by a single amino acid

被引:146
作者
Geha, RM
Rebrin, I
Chen, K
Shih, JC
机构
[1] Univ So Calif, Sch Pharm, Dept Mol Pharmacol & Toxicol, Los Angeles, CA 90089 USA
[2] Univ So Calif, Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90089 USA
关键词
D O I
10.1074/jbc.M006972200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Monoamine oxidase (MAO) is responsible for the oxidation of biogenic and dietary amines, It exists as two isoforms, A and B, which have a 70% amino acid identity and different substrate and inhibitor specificities. This study reports the identification of residues responsible for conferring this specificity in human MAO A and B, Using site-directed mutagenesis we reciprocally interchanged three pairs of corresponding nonconserved amino acids within the central portion of human MAO. Mutant MAO A-I335Y became like MAO B, which exhibits a higher preference for beta -phenylethylamine than for the MAO A preferred substrate serotonin (5-hydroxytryptamine), and became more sensitive to deprenyl (MAO B-specific inhibitor) than to clorgyline (MAO A-specific inhibitor). The reciprocal mutant MAO B-Y326I exhibited an increased preference for 5-hydroxytryptamine, a decreased preference for beta -phenylethylamine, and, similar to MAO A, was more sensitive to clorgyline than to deprenyl, These mutants also showed a distinct shift in sensitivity for the MAO A- and B-selective inhibitors Ro 41-1049 and Ro 16-6491. Mutant pair MAO A-T245I and MAO B-I236T and mutant pair MAO A-D328G and MAO B-G319D reduced catalytic activity but did not alter specificity. Our results indicate that Ile-335 in MAO A and Tyr-326 in MAO B play a critical role in determining substrate and inhibitor specificities in human MAO A and B.
引用
收藏
页码:9877 / 9882
页数:6
相关论文
共 30 条
[1]   CDNA CLONING OF HUMAN-LIVER MONOAMINE OXIDASE-A AND OXIDASE-B - MOLECULAR-BASIS OF DIFFERENCES IN ENZYMATIC-PROPERTIES [J].
BACH, AWJ ;
LAN, NC ;
JOHNSON, DL ;
ABELL, CW ;
BEMBENEK, ME ;
KWAN, SW ;
SEEBURG, PH ;
SHIH, JC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (13) :4934-4938
[2]   A 30 Å long U-shaped catalytic tunnel in the crystal structure of polyamine oxidase [J].
Binda, C ;
Coda, A ;
Angelini, R ;
Federico, R ;
Ascenzi, P ;
Mattevi, A .
STRUCTURE, 1999, 7 (03) :265-276
[3]   ABNORMAL-BEHAVIOR ASSOCIATED WITH A POINT MUTATION IN THE STRUCTURAL GENE FOR MONOAMINE OXIDASE-A [J].
BRUNNER, HG ;
NELEN, M ;
BREAKEFIELD, XO ;
ROPERS, HH ;
VANOOST, BA .
SCIENCE, 1993, 262 (5133) :578-580
[4]   AGGRESSIVE-BEHAVIOR AND ALTERED AMOUNTS OF BRAIN-SEROTONIN AND NOREPINEPHRINE IN MICE LACKING MAOA [J].
CASES, O ;
SEIF, I ;
GRIMSBY, J ;
GASPAR, P ;
CHEN, K ;
POURNIN, S ;
MULLER, U ;
AGUET, M ;
BABINET, C ;
SHIH, JC ;
DEMAEYER, E .
SCIENCE, 1995, 268 (5218) :1763-1766
[5]  
CESURA A M, 1988, Pharmacological Research Communications, V20, P51, DOI 10.1016/S0031-6989(88)80547-2
[6]   Investigation on the structure of the active site of monoamine oxidase-B by affinity labeling with the selective inhibitor lazabemide and by site-directed mutagenesis [J].
Cesura, AM ;
Gottowik, J ;
Lahm, HW ;
Lang, G ;
Imhof, R ;
Malherbe, P ;
Rothlisberger, U ;
DaPrada, M .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1996, 236 (03) :996-1002
[7]  
CESURA AM, 1989, MOL PHARMACOL, V37, P358
[8]  
Chen K, 1996, J NEUROCHEM, V66, P797
[9]  
CHEN K, 1994, MOL PHARMACOL, V46, P1226
[10]  
Crossen R., 1996, BACULOVIRUS EXPRESSI